---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-003944"
form_type: "8-K"
ticker: "WVE"
cik: "0001631574"
company_name: "Wave Life Sciences Ltd."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:20:16.747607+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Wave Life Sciences furnishes updated corporate presentation; no specific new facts disclosed

## Summary
- Filed an 8-K on January 8, 2024, to update its corporate presentation.
- Presentation available on Investor & Media section of company website; furnished as Exhibit 99.1.
- No financial results, pipeline milestones, or guidance changes are provided in the filing text.
- The exhibit content is not included in the provided text, so material changes cannot be assessed.

## SEC filing metadata
- accession: 0001193125-24-003944
- form_type: 8-K
- ticker: WVE
- cik: 0001631574
- company_name: Wave Life Sciences Ltd.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1631574/000119312524003944/0001193125-24-003944-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1631574/000119312524003944/d101072d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-003944
- JSON: https://secwatch.observer/filing/0001193125-24-003944.json
- Plain text: https://secwatch.observer/filing/0001193125-24-003944.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.